
Editorial
Select search scope: search across all journals or within the current journal

To determine the prevalence of sarcopenia and sarcopenic obesity (SO) in patients with type-2 diabetes mellitus (T2DM) and established cardiovascular disease (CVD).
This cross-sectional study included 60 T2DM patients (30 with CVD and 30 without, aged 40-70 years, 80% males). Data collection included body composition analysis using bio-impedance, hand grip strength measurement and gait-speed assessment. Sarcopenia was defined using the Asian Working Group for Sarcopenia (AWGS-19) guidelines, while SO was defined using a body-mass index, waist circumference and percentage of body fat. SPSS software version 23.0 was used.
Overall sarcopenia (including possible sarcopenia or sarcopenia) was found to be significantly higher in patients with CVD as compared to those without CVD (70% vs. 40%;
Our study found that the prevalence of overall sarcopenia was significantly higher in patients with T2DM and CVD compared to those without CVD. Sarcopenia appears to be a potential independent risk factor in predicting risk of CVD in patients with T2DM.
Ischemic Heart Disease (IHD) is the leading cause of mortality among cardiovascular disorders. There is inadequate knowledge about the prevalence of IHD in Bangladesh, particularly in diabetes mellitus patients. This research aimed to ascertain the frequency of IHD in diabetic individuals and to identify risk factors for IHD in rural areas.
A cross-sectional survey was in a rural community in a diabetic cohort. Simple random sampling was used to select 150 diagnosed diabetic patients of both genders, aged 30 to 65, from registration numbers within the diabetic cohort. Diagnosis of IHD was based on the history of established IHD and ECG and echocardiography findings.
The results showed that the prevalence of IHD among diabetic patients is 4%. The univariate binary logistic regression analysis identified significant factors associated with IHD, including older age (OR 1.15; 95% CI 1.01-1.31), higher body mass index (BMI) (OR 1.30; 95% CI 1.07-1.52), increased duration of diabetes (OR 1.13; 95% CI 1.00-1.28), and smokeless tobacco use (OR 5.26; 95% CI 1.00-27.7). However, after adjustment in the logistic regression model, a significantly higher risk of IHD was found to be associated with patients having a higher BMI (AOR 1.43, 95% CI 1.14-1.80) and a longer duration of diabetes (AOR 1.26, 95% CI 1.07-1.48).
The present data indicate that the prevalence of IHD in Bangladesh is 4%, which is a significant issue for diabetic individuals. Regular screening and careful monitoring are necessary among diabetic patients to reduce the risk of cardiovascular diseases, including IHD.
Thyroid diseases are common in India. Both insufficient and excess thyroid hormones cause adverse cardiovascular events. Subclinical hypothyroidism and hyperthyroidism while undiagnosed can lead to derangement of cardiac functions. This study aimed to explore thyroid function abnormalities among heart failure patients of different severity (NYHA class).
A descriptive, cross-sectional study was undertaken on 492 heart failure patients (246 males and 246 females) of age greater than 18 years. Patients were classified according to NYHA. Serum TSH and FT4 were investigated. Data were analyzed by standard statistical software.
The mean age of participants was 54.2 ± 13.1 years. Mean FT4 and TSH were 1.36 ± 0.39 ng/dL and 2.89 ± 1.15 mIU/L, respectively. Patients belonged to NYHA class II (35.4%), III (52.4%) and IV (12.2%). Comorbidities included Hypertension (38%), Diabetes Mellitus (29%) and Dyslipidemia (52%). Hypothyroidism and hyperthyroidism were present in 27% and 5% patients respectively in overt or subclinical forms. The prevalence of thyroid disorders among NYHA class II, III and IV patients were 17%, 37%, and 50%, respectively.
Thyroid disorders were present in about one-third of the patients with heart failure. The prevalence of hypothyroidism was almost five times that of hyperthyroidism. The prevalence of thyroid disorders increased with the severity of heart failure.
Cardiomyopathy, a rare heart disease, is characterized by abnormalities in cardiac wall thickness and chamber size, leading to impaired contraction, relaxation, conduction, rhythm, and reduced pumping ability.
This review aims to provide a comprehensive understanding of cardiomyopathy by examining its various aspects
A literature survey was conducted using online databases such as PubMed, Google Scholar, and Web of Science, covering publications from January 1995 to July 2023.
Genetic mutations in key muscle contraction genes (MYH7, MYL2, MYL3, MYBPC3, TNNT2, TPM1, TNNI3, ACTC) contribute to cardiomyopathy. Additionally, epigenetic markers in genes like FKBP5, TBX5, HAND1, POLA2, PLAAT3, and CCDC88B, along with environmental factors such as alcohol addiction, smoking, and stress, significantly influence disease risk. Genetic testing, including whole exome/genome sequencing, has revolutionized diagnosis, enabling early detection and intervention. Familial genetic testing facilitates personalized management.
Cardiomyopathy is a complex disease with genetic and environmental influences. Various techniques, including genetic testing, aid in its identification and management. Furthermore, machine learning (ML) techniques have emerged as valuable tools in understanding and predicting cardiomyopathy outcomes.
Coronary stent infection (CSI) is a rare but fatal complication of percutaneous coronary intervention (PCI) occurring in less than 0.1% cases. CSI usually manifests as fever and acute coronary syndrome but in some cases presentation may be confusing. Without prompt diagnosis and appropriate treatment, the outcome is poor with mortality reaching 30%. Here, we present 5 cases of CSI resulting in coronary artery aneurysms. Interestingly, CSI occurred during the first stent implantation, mostly in post-acute myocardial infarction patients. Blood culture, pericardial fluid analysis, and coronary angiogram were used as diagnostic tools in our cases. Three of our patients had infective endocarditis involving native mitral and aortic valves and one patient had pericardial effusion and cardiac tamponade. Stent thrombosis and aneurysm formation were observed in all cases. All patients received appropriate and adequate antibiotic therapy before undergoing coronary angiogram and surgery. Cardiac catheterization laboratory hardware reuse, repeated procedures, complex procedures requiring instrumentation, and prolonged indwelling catheters may increase the risk of bacteremia and stent infection. Currently, there are no established criteria or protocols for diagnosis and management of CSI.
Postinfective left ventricular pseudoaneurysm is extremely rare, and very few case reports are available in the literature. Ventricular pseudoaneurysm secondary to staphylococcal infection is usually managed through surgical intervention. We are presenting here a rare case of post-varicella disseminated
WPW syndrome with rheumatic mitral stenosis is a rare and deadly combination. We report a patient with the above combination, presenting with drug-refractory antidromic tachycardia due to left atrial flutter and marked dyspnea. She underwent successful radiofrequency ablation of left-sided accessory pathway, left atrial flutter, and percutaneous mitral commissurotomy in a single sitting.
Spontaneous coronary artery dissection (SCAD) often impacts young women who lack traditional risk factors. Diagnosing SCAD can be challenging due to its diverse angiographic presentations and resemblance to other conditions, such as organized thrombus.
We present two cases involving middle-aged male smokers, each experiencing chest pain lasting over 12 hours. Both patients exhibited ST-segment elevation in the anterior leads on ECG, anterior wall hypokinesia, and an LVEF of 40% on 2D echocardiography. Immediate coronary angiography revealed dye staining and multiple radiolucent lumens in the LAD, indicative of SCAD. Optical coherence tomography (OCT) identified an organized thrombus with a distinctive “Swiss cheese” pattern, differing from the usual radiolucent false lumen associated with SCAD. Both patients were successfully treated with PCI, including thrombus aspiration and stent placement.
Relying solely on angiography for SCAD diagnosis may overlook organized thrombus. Redefining SCAD criteria and utilizing multimodal imaging like OCT in all cases is essential.
Chronic total occlusion (CTO) percutaneous coronary interventions have more complications due to intrinsic complexity of procedure which is further compounded by ambiguity of proximal cap. If the ambiguous proximal cap CTO is at ostial left anterior descending artery (LAD), impact of complications is huge as the area of myocardium at risk is significant. Hence, while treating ambiguous proximal cap CTO at ostial LAD or left circumflex artery (LCX), special attention must be given to prevent or minimize inflow injuries like dissection or intramural hematoma (IMH) of left main coronary artery (LMCA) and its branches. In order to prevent such complications, all the available CTO techniques need to be understood in this context and executed to keep procedural outcomes as predictable as possible. Intravascular ultrasound (IVUS) imaging is the passkey in wiring and detecting inflow injury to prevent intraprocedural catastrophes. This article explores the refinement and modification of existing techniques of CTO PCI and the use of imaging in the context of ostial LAD CTO PCI.
Coronary stent infection leading to Acute bacterial pericarditis is a rare but critical condition associated with significant mortality and morbidity, often complicated by the development of pericardial effusion and cardiac tamponade. 1 In this case report, we present the case of a 30-year-old male patient with a history of diabetes, who experienced an acute inferior wall myocardial infarction and subsequently underwent primary percutaneous coronary intervention (PCI) to the right coronary artery (RCA). Approximately two weeks after the PCI, the patient developed pericardial effusion with impending cardiac tamponade, requiring a pericardiocentesis procedure that resulted in the aspiration of 200 mL of fluid. Analysis of the pericardial fluid revealed the presence of pus cells, low glucose, and growth of Pseudomonas aeruginosa in culture. Further evaluation, including FDG PET imaging, demonstrated increased tracer uptake in the area corresponding to the RCA stent, while coronary angiography revealed the presence of an RCA aneurysm. The patient received appropriate antibiotic therapy followed by resection of aneurysm. This case underscores the importance of recognizing and promptly managing coronary stent infection-related complications to optimize patient outcomes.
Valve infolding is one of the uncommon side effects of transcatheter aortic valve implantation (TAVI) with self-expandable valves (SEV). Acute hemodynamic collapse brought on by infolding frequently results in complications, such as periprocedural stroke. We present an unusual occurrence of infolding of the Evolut PRO valve. Removal and replacement of the valve should be considered as soon as infolding is discovered.
In this issue, we briefly overview the important trials presented at the European Society of Cardiology (ESC) Congress 2024 in London, United Kingdom. The trials are categorized under the following headings.

